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Advances in modern medicine invite the assumption that medicine can control human 
biology. There is a perilous logic that leads from expectations of medicine’s control over 
reproductive biology to the expectation of having a perfect baby. This article proposes 
that obstetricians should take a preventive ethics approach to the care of pregnant women 
with expectations for a perfect baby. We use Nathaniel Hawthorne’s classic short story, 
“The  Birthmark,” to illustrate the perils of the logic of control and perfection through 
science and then identify possible contemporary sources of the expectation of the perfect 
baby. We propose that the informed consent process should be used as a preventive ethics 
tool throughout the course of pregnancy to educate pregnant women about the inherent 
errors of human reproduction, the highly variable clinical outcomes of these errors, the 
limited capacity of medicine to detect these errors, and the even more limited capacity to 
correct them.  
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Patients often come to their physicians with requests for diagnostic tests and treatments, 
sometimes invasive tests and treatments. This is especially the case in obstetric practice. 
The prevalence with which pregnant women make requests of their obstetricians varies in 
different populations of pregnant women. However, obstetricians are familiar with–and 
are often troubled by– requests for diagnostic tests and for specific interventions, such as 
the detailed birth plans that some pregnant women present. These requests for clinical 
management obviously reflect the values and priorities of pregnant patients and therefore 
should be taken seriously. 
 
Sometimes, however, such requests reflect something more: the quest for control over human 
biology and the pursuit of perfection that such control should attain. The expectation of a perfect baby 
follows logically from the expectation that medicine can control human biology. This logic of expectations 
of control and perfection can become perilous. Sometimes this logic is expressed in requests that cause 
obstetricians to become uncomfortable, eg, when a birth plan is internally inconsistent or sets conditions 
such as no analgesia or no cesarean delivery that, later, may not be consistent with evidence based clinical 
reasoning and therefore professional integrity. The logic of expectations of control and perfection can also 
lead to rejection of resuscitation in the delivery room or of subsequent neonatal critical care, even when 
these are reliably expected to be life saving and achieve a good functional outcome. 
 
In short, the logic of expectations of control and even perfection of pregnant women who embrace 
this logic is fraught with the potential for ethical conflict. The purpose of this article is to identify some of 
the sources for this ethical conflict and propose a preventive ethics approach to replacing the logic of the 
expectations of control and perfection with more realistic and therefore more appropriate expectations. 
 
The perils of the logic of expectations of control and perfection: a cautionary tale  
 
We start with one of the most compelling accounts of the perils of the logic of 
expectations of control and perfection in medicine, Nathaniel Hawthorne’s1 (1804-1864) 
“The Birthmark.” Brilliantly anticipating the problems we address, Hawthorne relates the 
story of a woman renowned for her beauty, named Georgiana. Her beauty, however, 
appears incomplete: she has a birthmark in the shape of a hand on her cheek. Aylmer, her 
husband, comes to dislike his wife’s birthmark. Georgiana, perhaps as a result of 
Aylmer’s influence, comes to dislike her birthmark as well. Alymer plans to use his 
scientific skills to eradicate the birthmark and make his wife’s beauty complete, perfect. 
His thinking epitomizes the logic that leads inexorably from an exaggerated expectation 
of scientific control over human biology to its perfection. 
 
Driven by this logic, Aylmer prepares a special liquid, a “chemical experiment,” 
to rid her of the birthmark. He assures her: “The concoction of the draft has been perfect. 
. . . Unless all my science have failed me, it cannot fail.” Despite concern for danger, 
Georgiana duly consumes the “powerful cosmetic.” She falls into a sleep and her 
birthmark begins to disappear. Her first words on awakening are “My poor Aylmer.” 
“‘Poor? Nay, richest, happiest, most favored!’ exclaimed he. ‘My peerless bride, it is 
successful! You are perfect!’” She is also dying and expires as her birthmark fades 
altogether from her cheek. The expectation of control over human biology and the pursuit 
of perfection encouraged by such an expectation have exacted a terrible price. 
 
The perils of the logic of expectations of control and perfection in pregnancy 
 
A directly parallel logic of expectation of control and pursuit of perfection in 
pregnancy today can also exact a price, though, of course, not so terrible. This article will 
take a preventive ethics approach to the imperfect concept of a perfect baby. Preventive 
ethics has 2 components: (1) identifying the conditions in clinical practice that can lead to 
ethical conflict; and (2) using the informed consent process to address and defuse 
conditions that create the potential for conflict.2 The conditions in clinical practice that 
promote the concept of the perfect baby and can lead to ethical conflict in the care of 
pregnant patients are exaggerated expectations about the ability to control human 
reproductive biology. We will first identify these conditions and then describe an 
informed consent process designed to defuse the logic of expectations of control and 
perfection. 
 
Modern fetal diagnosis and therapy feed public expectations of medicine’s ability 
to control human reproductive biology. In a single generation, technological and 
interpretive advances have transformed fetal imaging. In the developed world we have 
long ago left the world of grainy, bistable, static images that few physicians were 
competent to interpret. We now have 4-dimensional, real-time ultrasound images that can 
be easily appreciated by the lay public who have never before seen an ultrasound image 
of a developing fetus. Physicians, long accustomed to imaging technology, look on the 
results with a diagnostic eye, what Foucault3 called the “clinical gaze.” The clinical gaze 
appropriately medicalizes what it sees, because physicians are expected to diagnose and 
manage fetal abnormalities. One result is that the fetus may become a patient who can be 
diagnosed and treated, analogous to a newborn infant.4 
 
The lay or social gaze is not the same, because, as a rule, it is scientifically and 
clinically untrained. Laypersons see pictures of babies, not images of anatomy and 
physiology. Pregnant women and those involved in their pregnancies with them see an 
immediate and visually arresting picture of the fetus, sometimes with a coppery shimmer. 
Magnetic resonance pictures can be even more visually arresting, especially of the fetal 
head and facial features. The experience of “seeing” the fetus can be a moving and 
bonding experience for the pregnant woman and her partner. 
 
Given the intensity and power of fetal pictures, it is not unreasonable for 
laypersons to assume that the well-trained physician can see everything and therefore 
control human biology and thereby assure perfection. This linking of an expectation of 
control with the pursuit of perfection can feed the expectation that medicine can predict 
human reproductive biology with little or no risk. After all, fetal images can be made 
routinely, simultaneously, and without risk. It is a small next step to the expectation that 
medicine can predict the perfect baby. 
 
Invasive fetal diagnosis from chorion villus sampling or amniocentesis results in 
karyotyping that is virtually certain in its ability to diagnose obvious aneuploidy. 
Karyotyping can encourage binomial thinking among some physicians that either there is 
a chromosomal abnormality or not, with the absence of abnormality resulting in 
reassurance.
5
 The lay translation can be quite different: either something is wrong or 
everything is fine. What the physician thinks is simply reassurance can nonetheless 
encourage the expectation of perfection for the patient. 
 
It is common knowledge that cesarean delivery can be life saving for the fetus, eg, 
from complete placenta previa or prolonged bradycardia. It is also common knowledge 
that cesarean delivery can reduce morbidity, eg, from breech presentation. The 
introduction of steroid therapy to enhance fetal lung maturity has been shown to improve 
outcomes for infants born prematurely. Quality prenatal care that is initiated early in the 
pregnancy does not guarantee the prevention of prematurity. The administration of folic 
acid at 400 _g/d throughout pregnancy can markedly reduce the incidence of neural 
defects, however it does not prevent all neural tube defects.6,7 The introduction of 
RhoGAM (Ortho-Clinical Diagnostics, Raritan, NJ) has markedly reduced the incidence 
of erythroblastosis fetalis. Intrauterine blood transfusion, though rarely needed for this 
condition, is the most well-established form of invasive fetal therapy and can be life 
saving for the fetus. More invasive forms of experimental fetal therapy, while performed 
only in a few centers, have been introduced. The publicity that can surround such surgery 
can give it an impact on public expectations that can be considerable, eg, in the common 
use of “miracle” to describe such innovative fetal therapy.8 Hospitals are not above 
encouraging such publicity, to market themselves in wider national and international 
markets. The drama of the publicity about such fetal therapy in the public arena obscures 
the rarity of its occurrence and clinical utility. The impression that fetal therapy is an 
expanding option encourages the belief in the ever-expanding power of medicine to 
control human reproductive biology. 
 
The consumer rights movement has appropriately encouraged patients, especially 
pregnant patients, to speak up for themselves. The discourse of patients’ rights can be 
misused, especially when it encourages patients to make excessive demands on 
physicians, eg, presenting detailed birth plans and requesting cesarean delivery in the 
absence of either fetal or maternal indications.9 Sometimes implicit in these expressions 
of patients’ rights is the belief that laypersons can set the standard of care for clinical 
practice. The failure of physicians to adhere consistently to the discipline of evidence-
based reasoning in obstetric practice has, ironically, supported this belief. It is a small 
step from the belief that laypersons can set the standard of care to the belief that patients 
can control human reproductive biology by making the right demands on their 
obstetricians. 
 
Scientifically disciplined clinical judgment does not support the generalization 
from occasional success in clinical practice to uniform success. Lay thinking that is not 
scientifically disciplined can support this mistaken generalization. If patients have the 
belief that physicians can control human reproductive biology, bad outcomes must be the 
result of defective clinical judgment and practice, ie, malpractice. 
 
The safe, effective termination of pregnancy before viability can encourage the 
belief that a pregnant woman can control all the outcomes of pregnancy. This belief may 
mean that the errors of human reproduction can be detected through fetal diagnosis and 
eliminated through termination of pregnancy. The biological reality is that not all less-
than-perfect outcomes can be detected prenatally.  
 
Fashioning the informed consent process to prevent exaggerated expectations about 
the ability to control human reproductive biology 
 
The informed consent process should be used by obstetricians early in prenatal 
care, or ideally, preconception, as a preventive ethics tool to defuse exaggerated 
expectations about the ability to control human biology.2 The first step in this informed 
consent is to provide patients with a succinct education about the imperfections of human 
reproduction and the limits of medicine to alter these imperfections (Table 1).10,11 
 
No pregnant woman should begin her pregnancy with the idea that anyone can 
guarantee the birth of a normal baby. While there are some preventive measures (Table 
2), such as vaccination against German measles (rubella vaccine), taking adequate 
amounts of folic acid (400 µg/d as a minimum),12 some birth defects cannot be prevented. 
The concept to communicate is that the ability of medicine or patient’s behaviors to 
improve outcomes is limited. Therefore, we cannot guarantee that every birth will be 
normal. This information should be communicated as part of routine prenatal care.2  
 
All physicians who care for pregnant women should be aware of the pertinent 
scientific information on background reproductive risks (Table 1)10,11 and the etiology of 
congenital malformations (Table 3).10,11 In addition, while there are high-risk conditions 
such as multiple gestation, prematurity with its complications such as cerebral palsy and 
bronchopulmonary dysplasia can occur in any pregnancy as well as in full-term newborns 
(Table 1). The physician should strive for a term pregnancy, although doing so is no 
guarantee that the risks usually associated with prematurity cannot occur in full-term 
newborns. 
 
Patients do not need to be provided this information in detail but do need to be 
informed about the risks of birth defects, miscarriage, and prematurity. Every pregnant 
woman should be told the following information (adjusted for the patient’s educational 
level): “If you are healthy and have no personal or family history of reproductive or 
developmental defects, you began your pregnancy with a 3% risk of birth defects. Once 
you knew you were pregnant, having missed your first menstrual period, you had a 15% 
risk of miscarriage. There is also a risk of prematurity and complications. These risks 
apply to all pregnant women.” Physicians should be clear with patients that many 
congenital malformations (Table 3) have an unknown etiology so that, if a birth defect 
occurs, blame will not be inappropriately attributed to patients’ behaviors, exogenous 
exposures, or obstetric management.13,14  
 
Ultrasound technology and genetic diagnosis can identify many anomalies. 
However, pregnant women need to know that, although we have made great advances in 
the past 50 years, we are not close to being able to diagnosis or predict every genetic 
disease, anatomical malformation, or biochemical defect in each pregnancy and thus 
guarantee a normal pregnancy. 
 
Obstetricians need to be aware of the reasons why we cannot diagnose all 
developmental problems. Some genetic diseases and hereditary anatomical 
malformations are due to mutations that occur during oogenesis or spermatogenesis (the 
development of the sperm or the ovum) (Table 1). Therefore, there is no family history of 
these diseases. Chromosomal microarray analysis has the potential to identify thousands 
of genetic diseases and disorders, outstripping the current diagnostic capacity of 
karyotyping by amniocentesis or chronic villus sampling.15 However, even when genetic 
abnormalities or hereditary anatomical defects are discovered by diagnostic tests, there 
may be no information about the clinical significance of such findings. Many anatomical 
malformations may not be recognizable in utero and will not be able to be diagnosed for 
months, or even years, after the child is delivered. Autism, polycystic kidney disease, 
mental retardation, learning disability, schizophrenia, and many other serious behavior 
disorders are in this category. While many congenital malformations can be diagnosed in 
utero, attempts to treat the fetus surgically or medically are often experimental, are not 
curative, and continue to have significant risks of mortality and morbidity. 
 
Even if experimental fetal therapy is available, it is uncertain if it should be 
utilized. Once a developmental diagnosis had been confirmed, it is not an easy task to 
determine what can be done (pregnancy interruption, in utero therapy, or expectant 
management). Physicians should be aware that many couples are willing to embark on 
experimental intervention in the mistaken assumption that, in their case, it will work. 
Physicians should be prepared to disabuse pregnant women who believe that the 
intervention will work and therefore do not appreciate its experimental nature, a 
confusion misconception.” Finally, it is important to emphasize that many pregnant 
patients are optimistic about the advances in medicine and are confident that their 
physicians will solve all problems that could occur with their pregnancy. However, this 
version of the expectation of a perfect baby assumes powers of medicine to control 
human reproduction that medicine does not possess. There will almost certainly continue 
to be a significant percentage of anatomical birth defects that result from unpreventable 
developmental errors. 
 
Conclusion 
 
The obstetrician whose patient expresses the hope for a perfect baby should give 
this matter the serious and sensitive attention it deserves: a preventive ethics approach 
designed to educate the pregnant woman about the inherent errors of human 
reproduction, the highly variable clinical outcomes of these errors, the limited capacity of 
medicine to detect these errors, and the even more limited capacity to correct them. The 
message to convey is that perfection in pregnancy is not attainable now or even in the 
foreseeable future. Some pregnant women may be influenced by the expectation of 
perfection and therefore may believe that anything less is a disaster. Appropriate 
counseling can help them to realize that the fetus’ condition and prospects are better than 
they think. 
 
Physicians should keep in mind and help patients appreciate the ancient wisdom 
of the Hippocratic text, The Art,16 which emphasizes that the power of the art and science 
of medicine to alter the course of disease and injury is always limited. When physicians 
ignore these limits, they experience a kind of “madness” from which Aylmer suffered, ie, 
expecting more from medicine than its limited diagnostic and therapeutic capacities 
justify. In “The Birthmark,” we can now see that Aylmer failed to meet the standards of 
preventive ethics and evidence-based reasoning when he said, “The concoction of the 
draft has been perfect. . . . Unless all my science have failed me, it cannot fail.”1 Aylmer 
is thus an exemplar of what physicians should not do in response to the quest for the 
perfect baby. 
 
In more contemporary terms, clinical judgment should be disciplined by scientific 
information of the kind we have presented. The preventive ethics response in the search 
for the perfect baby should use the informed consent process to discipline the 
expectations of pregnant women to the greatest extent possible. We believe that this 
preventive ethics approach should be taken with every pregnant woman, to prepare her 
for the inherent uncertainties of pregnancy and its clinical management. Physicians 
should assume that, with adequate counseling and support, pregnant women are indeed 
capable of making scientifically disciplined decisions, if informed consent is 
appropriately evidence based, as has been shown for decision making about invasive 
prenatal diagnosis after first-trimester risk assessment.17  
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